Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone versus dexmedetomidine injection for plantar fasciitis heel pain
IRCT20170423033615N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in plantar fasciitis comparing Dexmedetomidine + lidocaine with Triamcinolone + lidocaine (2 arms). Primary endpoint: Pain level. Started Nov 2022; status: completed.
02
Drugs
dexmedetomidinetriamcinolonelidocaine
03
Conditions
plantar fasciitis
Beyond the preview
Go deeper on IRCT20170423033615N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170423033615N2.